Dual Receptor Targeting This synthetic peptide, consisting of 39 amino acids, activates both GIP and GLP-1 receptors with a single molecule, providing synergistic metabolic effects that surpass single-target approaches
However, tirzepatide slows gastric emptying, which can affect absorption of oral medications
Patients with Liver Disease For those with cirrhosis, hepatitis, or a history of heavy alcohol use, the liver cannot process acetaminophen efficiently
Flu-like symptoms are not listed as a common or characteristic adverse effect in the FDA-approved prescribing information for tirzepatide
Meet face to face with your local provider Review your health history, labs, and goals to determine the right plan